Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by BearDownAZon Apr 12, 2013 3:34pm
458 Views
Post# 21248510

Record and meeting dates

Record and meeting dates

There has been confusion on the board today as to what the record and meetings dates actually mean. The record date (currently proposed to be April 25th) is the date cutoff to determine which shareholders are eligible  to vote at the meeting (currently proposed to be May 28th). April 25th is not a cutoff date for participating in the proposed Spinco/RVX Therapeutics arrangement. Since we don't know the exact details of what we'll be voting on, it is impossible to say right now whether May 28th will or will not be a participation date cut off for getting shares of RVX Therapeutics. But I'm almost certain April 25th is only the right to vote cut off date. Am I right here? 

Bullboard Posts